BioSpace News Archive

Deals

Soleno Therapeutics Announces Closing of $15.4 Million Public Offering of Common Stock - Oct. 25, 2019

Soleno Therapeutics, Inc., announced the closing of its previously announced underwritten public offering of 12,841,667 shares of its common stock, including 1,675,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a public offering price of $1.20 per share.

October 25, 2019
·
3 min read
Genetown

PerkinElmer to Present at Wolfe Research Healthcare Conference

PerkinElmer, Inc announced that the Company will present at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019, at 8:00 a.m. ET at the Marriott East Side Hotel in New York.

October 25, 2019
·
1 min read
Deals

Innovia Medical Announces Acquisition of DTR Medical

Innovia Medical announced its partnership with DTR Medical.

October 25, 2019
·
1 min read
Business

CORRECTING and REPLACING Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2019

Bioasis Technologies Inc. announced it has filed its unaudited financial statements and management’s discussion and analysis for the period ended August 31, 2019

October 25, 2019
·
2 min read
Policy

Georgia Bio Statement on BD Sterilization Plant In Georgia;

Closure May Lead to Medical Device Shortage & Impact Patients

October 25, 2019
·
2 min read
Business

Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance

Mylan Pharmaceuticals Inc. is conducting a voluntary nationwide recall of one lot of Alprazolam Tablets, USP C-IV 0.5 mg, to the consumer/user level.

October 25, 2019
·
3 min read
Business

Charles T. Foscue Elected Chairman of the Doheny Eye Institute Board of Directors

Doheny Eye Institute has announced that Charles T. Foscue has been elected as Chairman of the DEI Board of Directors. Mr. Foscue was preceded by Edward A. Landry, who served as chairman for 20 years prior to retiring from the Board in September..

October 25, 2019
·
3 min read
Policy

Information Update - Additional ranitidine products recalled as a precautionary measure; request to stop distribution remains in place while Health Canada continues to assess NDMA

Dominion Pharmacal, Laboratoire Riva Inc., Pharmascience Inc. and Vita Health Inc. are recalling all lots of their prescription and over-the-counter ranitidine products from the Canadian market as a precautionary measure.

October 25, 2019
·
8 min read